Diaper [napkin] dermatitis

L12_DIAPER

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L22 Hospital discharge: ICD-9 — 6910 Cause of death: ICD-10 — L22 Cause of death: ICD-9 — 6910 2 out of 7 registries used, show all original rules.	60
4. Check minimum number of events None	60
5. Include endpoints None	60
6. Filter based on genotype QC (FinnGen only)	54

Control definitions (FinnGen only)

Control exclude: L12_DERMATITISECZEMA

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L20-L30
Name in latin: Dermatitis glutealis infantum

NAME	L12_DIAPER
CONTROL_EXCLUDE	L12_DERMATITISECZEMA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L22
HD_ICD_9	6910
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L22
COD_ICD_9	6910
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Diaper [napkin] dermatitis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	1887	1086	800
Only index persons	809	478	331
Unadjusted period prevalence (%)
Whole population	0.03	0.03	0.02
Only index persons	0.02	0.02	0.01
Median age at first event (years)
Whole population	1.03	1.01	0.96
Only index persons	1.14	1.10	1.21

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	54	36	18
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	2.42	2.28	2.71

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
60: Matched controls
600

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L22

ICD-10 Finland

Diaper [napkin] dermatitis

+∞

61.3

L20.0

ICD-10 Finland

Besnier prurigo

+∞

13.0

6910A

ICD-9 Finland

Atopic dermatitis and related conditions, Diaper or napkin rash

+∞

11.8

E0000UV, ,

ATC

5.0

8.7

146

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

14.6

6.9

A28

ICPC

Limited function/disability NOS

5.2

6.6

TQW80

NOMESCO Finland

Local dermatologic skincare

+∞

6.4

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

+∞

6.4

L27.2

ICD-10 Finland

Dermatitis due to ingested food

+∞

6.4

D07AA02

ATC

hydrocortisone; topical

4.9

6.3

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40758558) Short blood count panel - Blood

137

3.38

5.09

5.7

11.9

—

(3000991) Gas panel - Venous blood

3.24

3.81

10.1

13.9

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

7.49

3.81

1.6

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

7.49

3.81

1.6

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

5.68

3.53

1.1

1.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2.77

3.04

3.5

3.7

4.31

1.12

e6/l

0.92

(3048929) Epstein Barr virus Ab [Presence] in Serum

3.85

3.00

2.2

2.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

3.00

2.98

2.8

1.9

—

(3024928) Oxygen saturation in Venous blood

7.25

2.94

7.5

39.9

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3.02

2.86

3.4

4.1

1160.89

539.59

ng/l

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

5.50

2.82

1.3

6.2

4.14

3.34

mmol/l

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

161

2.39

2.70

7.3

4.2

—

(3026008) Bacteria identified in Urine by Culture

130

2.41

2.63

6.3

2.6

—

(3012544) pH of Venous blood

2.65

2.62

10.4

13.0

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

7.65

2.60

5.4

5.7

13.54

10.70

mg/l

—

(3030467) Casts [#/volume] in Urine by Automated count

139

2.37

2.58

5.3

4.0

0.04

0.15

e6/l

0.94

111

(40761535) Cells panel - Urine sediment

4.23

2.56

9.5

3.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

4.80

2.56

1.3

5.6

375.57

624.13

mg/l

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

4.25

2.33

2.9

3.2

—

(3023368) Bacteria identified in Blood by Culture

2.43

2.31

5.7

4.8

—

(3002582) Erythrocytes [#/volume] in Urine

153

2.23

2.31

5.3

4.3

25.23

424.09

e6/l

0.49

122

(3016018) Differential panel - Cerebral spinal fluid

5.94

2.26

1.2

6.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

3.53

2.18

1.5

7.2

169.13

169.52

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2.40

2.17

3.8

3.6

0.45

0.40

e6/l

0.07

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3.63

2.03

1.3

2.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

3.02

2.03

12.9

5.9

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

289

2.15

2.03

11.2

12.0

3.73

3.82

e9/l

0.12

235

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

4.04

1.99

1.2

2.1

—

(3000494) Fungus identified in Specimen by Culture

2.70

1.98

1.8

1.4

—

(3045414) Leukocytes [Presence] in Urine

4.85

1.98

1.6

1.2

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

188

2.05

1.94

6.2

7.8

9.66

20.26

umol/l

2.74

175

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

105

2.18

1.91

4.2

3.6

—

(3042936) Bacteria identified in Isolate by Culture

2.53

1.88

2.4

2.3

—

(36304419) Bacteria [Presence] in Urine

140

2.04

1.80

5.5

4.0

—

(3044290) Cell count panel - Cerebral spinal fluid

4.09

1.75

1.4

6.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.65

1.72

3.8

1.9

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

3.39

1.71

10.8

16.9

0.60

0.66

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

204

1.94

1.70

3.9

3.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2.13

1.69

1.5

3.4

1.43

1.39

mg/l

0.02

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2.20

1.68

13.1

15.2

25.67

24.89

mmol/l

0.28

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.52

1.65

3.7

1.9

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

3.21

1.62

10.8

16.1

1.18

1.02

—

(4035726) Immunohistochemistry procedure

2.64

1.60

1.4

1.7

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

168

1.84

1.42

2.3

1.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

142

1.87

1.41

1.6

1.8

1.89

2.16

g/l

0.24

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

472

2.44

1.37

12.4

9.1

32.02

23.52

u/l

0.45

446

(3004119) Hemoglobin [Mass/volume] in Venous blood

2.66

1.34

10.8

16.4

132.67

131.79

g/l

—

(3044640) Blood type and Crossmatch panel - Blood

136

1.84

1.32

4.3

3.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

2.93

1.31

1.4

1.1

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2.14

1.26

7.4

3.2

2.35

2.42

g/l

0.13

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

2.77

1.24

4.4

2.4

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

2.77

1.24

4.4

2.4

—

(3018418) pH of Serum or Plasma

114

1.83

1.20

10.4

3.3

—

7.39

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1.97

1.18

5.3

5.1

306.38

8952.36

umol/l

0.78

(3015235) Bicarbonate [Moles/volume] in Capillary blood

2.50

1.11

5.2

26.9

24.38

24.28

mmol/l

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

2.50

1.11

2.2

1.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

482

2.20

1.09

25.2

12.0

24.81

22.67

mg/l

0.23

349

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

118

1.75

1.07

1.9

2.4

46.33

64.69

u/l

0.82

109

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.84

1.06

1.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

136

1.71

1.05

2.8

1.6

88.58

98.16

pmol/l

0.43

(3018095) Leukocytes [#/volume] in Urine

190

1.65

1.04

7.2

4.8

19.57

60.89

e6/l

1.10

129

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1.94

1.02

3.6

2.6

285.67

359.29

nmol/l

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

111

1.74

1.02

7.9

3.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

248

1.62

1.01

11.7

9.0

—

(3031040) Bacteria [#/volume] in Urine by Automated count

301

1.60

0.93

9.3

4.5

—

29.40

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

123

1.66

0.91

2.1

1.9

—

(3037467) Urinalysis macro (dipstick) panel - Urine

323

1.59

0.89

8.3

4.6

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1.78

0.86

12.8

8.4

23.96

24.19

mmol/l

0.19

(3013826) Glucose [Moles/volume] in Serum or Plasma

265

1.55

0.85

9.2

7.8

6.75

6.12

mmol/l

0.37

233

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.95

0.77

2.6

1.4

—

(1761868) Lipid panel - Serum or Plasma

129

0.56

0.74

1.5

1.9

—

(3005322) IgE [Units/volume] in Serum or Plasma

1.80

0.73

3.3

1.1

3232.86

62.11

u/ml

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.75

0.71

16.6

11.3

104.71

105.12

mmol/l

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.93

0.70

1.0

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1.93

0.70

9.0

8.1

106.00

127.59

g/l

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.93

0.70

2.0

1.6

—

(3009343) pH of Capillary blood

1.61

0.67

13.8

11.5

—

7.42

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1.79

0.65

2.2

2.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

124

0.59

0.63

4.6

3.6

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1.73

0.63

1.2

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.61

0.0

1.6

—

(40768804) Tissue Pathology biopsy report

144

1.47

0.61

2.4

1.8

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

0.00

0.60

0.0

1.6

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

444

1.57

0.60

31.9

15.2

3.99

3.96

mmol/l

0.30

423

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.74

0.59

2.3

1.5

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

446

1.54

0.56

31.7

15.3

139.73

139.38

mmol/l

0.77

427

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1.53

0.56

25.3

12.5

1.16

1.33

mmol/l

1.39

(46235355) HIV 1 and 2 tests - Meaningful Use set

156

1.42

0.55

2.0

2.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.59

0.54

4.1

1.8

—

(3019150) Specific gravity of Urine by Refractometry

1.47

0.46

9.4

4.0

—

1.01

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.67

0.44

2.0

3.7

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.44

0.44

1.8

—

(3003396) Base excess in Arterial blood by calculation

1.56

0.42

9.2

14.3

2.98

0.48

mmol/l

—

(3004588) Protein electrophoresis panel - Serum or Plasma

0.00

0.41

0.0

2.0

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

0.00

0.41

0.0

3.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

108

1.39

0.40

2.0

2.4

—

(3022313) Gas panel - Capillary blood

1.47

0.40

15.1

10.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.47

0.40

2.1

1.9

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.34

0.39

2.7

1.5

—

(3002256) Pathology report gross observation

1.40

0.35

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

101

1.37

0.35

1.6

2.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

418

1.31

0.32

4.5

3.9

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.36

0.32

2.1

2.0

—

(36660697) Celiac disease serology panel - Serum

1.33

0.29

1.0

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

158

0.77

0.28

10.2

3.8

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.38

0.24

1.2

1.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

107

1.27

0.24

4.8

3.7

46.34

99.84

ng/l

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.21

0.22

1.2

1.4

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

2.1

—

(1002224) Polysomnography panel

0.00

0.21

0.0

1.0

—

(40768443) Skin Pathology biopsy report

0.00

0.21

0.0

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

0.21

0.0

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

0.00

0.21

0.0

1.6

—

0.66

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.00

0.21

0.0

1.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

0.00

0.21

0.0

1.3

—

(40768797) Stomach Pathology biopsy report

1.28

0.21

1.5

1.2

—

(3037522) Nuclear Ab [Titer] in Serum

1.28

0.21

1.3

1.4

—

617.78

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1.26

0.19

1.3

1.8

1.36

1.45

mmol/l

0.09

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

0.75

0.18

2.4

6.2

3.38

2.31

ug/l

—

(3029937) Albumin [Presence] in Urine by Test strip

111

1.22

0.17

10.1

4.1

0.00

0.02

estimate

—

(3021601) Nitrite [Presence] in Urine by Test strip

218

1.17

0.17

9.1

5.6

0.00

estimate

—

(3013512) EKG study

1.13

0.16

4.8

3.9

—

(3035350) Ketones [Presence] in Urine by Test strip

220

1.15

0.15

7.6

3.8

0.00

estimate

—

(3015736) pH of Urine

189

0.86

0.14

8.4

3.6

—

6.50

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

108

0.80

0.14

2.0

1.9

—

(40761511) CBC panel - Blood by Automated count

491

1.26

0.14

23.7

9.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

116

0.83

0.13

1.5

1.7

—

(3009261) Glucose [Presence] in Urine by Test strip

222

1.14

0.12

7.5

3.9

0.00

estimate

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1.07

0.09

1.4

1.6

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1.15

0.09

1.2

—

42.93

—

(3003694) ABO and Rh group [Type] in Blood

166

1.12

0.09

1.7

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

336

1.10

0.08

18.8

9.4

94.57

92.84

ml/min/173m2

0.11

252

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

358

1.09

0.06

4.6

3.7

4.32

4.45

mmol/l

0.40

328

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

358

1.09

0.06

4.9

4.0

2.44

2.61

mmol/l

0.59

324

(3020564) Creatinine [Moles/volume] in Serum or Plasma

461

1.09

0.04

26.5

12.8

73.83

63.89

umol/l

0.34

461

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

321

1.06

0.03

5.6

4.8

37.04

37.80

mmol/mol

0.16

299

(3044889) 12 lead EKG panel

225

0.96

0.00

4.3

3.2

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

-0.00

0.0

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

0.00

-0.00

0.0

4.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

-0.00

0.0

1.4

—

(44813793) Dust mix specific IgE antibody measurement

0.00

-0.00

0.0

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

-0.00

0.0

1.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

0.00

-0.00

0.0

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.00

-0.00

0.0

6.6

—

(3027315) Oxygen [Partial pressure] in Blood

0.00

-0.00

0.0

2.4

—

10.91

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

-0.00

0.0

4.4

—

106.20

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

-0.00

0.0

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

(3000012) Reticulocyte production index

0.00

-0.00

0.0

2.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.00

-0.00

0.0

6.6

—

(3038515) Glucose [Moles/volume] in Venous blood

0.00

-0.00

0.0

3.5

—

6.28

—

(3049717) Cytology report of Urine Cyto stain

0.00

-0.00

0.0

2.0

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.4

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

2.2

—

36.67

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(3028271) Lactate [Moles/volume] in Capillary blood

0.00

-0.00

0.0

1.3

—

1.63

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1.02

-0.00

2.6

4.9

16.50

20.93

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.7

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

-0.00

0.0

4.4

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

-0.00

0.0

4.4

—

3.78

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

-0.00

0.0

1.8

—

(21494434) Karyotype in Bone marrow

0.00

-0.00

0.0

1.8

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.88

-0.00

1.4

1.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

-0.00

0.0

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

3.9

—

11.71

—

(3026820) Hemoglobin [Mass/volume] in Venous cord blood

0.00

-0.00

0.0

1.0

—

165.60

—

(3051651) Icteric interference index of Serum or Plasma

0.00

-0.00

0.0

2.9

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

-0.00

0.0

1.2

—

(3013290) Carbon dioxide [Partial pressure] in Blood

0.00

-0.00

0.0

2.4

—

4.79

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

0.00

-0.00

0.0

1.3

—

13.17

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

0.00

-0.00

0.0

1.8

—

53.33

—

(3004809) Band form neutrophils/100 leukocytes in Blood

0.00

-0.00

0.0

5.3

—

3.00

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

-0.00

0.0

1.6

—

(3008037) Lactate [Moles/volume] in Venous blood

0.00

-0.00

0.0

3.3

—

1.49

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

0.00

-0.00

0.0

1.8

—

3.84

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

0.00

-0.00

0.0

1.3

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_DIAPER and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have L12_DIAPER.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: L12_DIAPER – Diaper [napkin] dermatitis

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Diaper [napkin] dermatitis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints